Basics Biofrontera Inc. IPO Date: October 29, 2021 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $6.04M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 5.03% Avg Daily Range (30 D): $0.02 | 2.81% Avg Daily Range (90 D): $0.03 | 3.20% Institutional Daily Volume Avg Daily Volume: 1.55M Avg Daily Volume (30 D): .09M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 272 Avg Trade Size (Sh.) (30 D): 464 Avg Trade Size (Sh.) (90 D): 406 Institutional Trades Total Inst.Trades: 27 Avg Inst. Trade: $1.17M Avg Inst. Trade (30 D): $2.12M Avg Inst. Trade (90 D): $2.12M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $.74M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 4.51K         News May 1, 2025 @ 6:38 PM Biofrontera and Almirall Launch the Hats On Challe... Source: N/A Mar 21, 2025 @ 12:00 PM Biofrontera Inc. Reports Record Fiscal Year 2024 F... Source: N/A Nov 13, 2024 @ 10:15 PM Biofrontera Inc. Reports Third Quarter and Nine-Mo... Source: N/A May 13, 2024 @ 9:10 PM Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops ... Source: Zacks Equity Research May 9, 2024 @ 10:55 PM Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss,... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.47 $.17 $-3.22 Diluted EPS $-.47 $.17 $-3.22 Revenue $ 8.59M $ 12.56M $ 37.32M Gross Profit $ $ $ Net Income / Loss $ -4.2M $ -1.4M $ -17.76M Operating Income / Loss $ -4.55M $ -1.71M $ -17.21M Cost of Revenue $ $ $ Net Cash Flow $ -4.12M $ 3.03M $ 4.56M PE Ratio     Splits Jul 05, 2023:   1:20